Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: DEA mail-order ephedra distribution guidance

This article was originally published in The Tan Sheet

Executive Summary

DEA mail-order ephedra distribution guidance: Issued by the Drug Enforcement Administration in the Feb. 7 Federal Register as part of the gradual implementation of regs under the 1996 Comprehensive Methamphetamine Control Act. The temporary guidance defines for those distributors who must make a monthly report to the Attorney General what constitutes "nonregulated persons" to whom these products are sold. The products covered by the reporting requirement include ephedrine, pseudoephedrine and phenylpropanolamine that are distributed either through the Postal Service or private or commercial carriers...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086663

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel